산화오파민

6-Hydroxydopamine

HCID 4624CAS 1199-18-4

기본 정보

표준 SMILES
NCCc1cc(O)c(O)cc1O
InChIKey
DIVDFFZHCJEHGG-UHFFFAOYSA-N
분자식
C8H11NO3
평균 분자량
169.18 g/mol
단동위원소 질량
169.07389321

개요

6-hydroxydopamine is a solid. Used as a pharmacological agent.

이름 및 식별자

우선 이름
6-Hydroxydopamine
IUPAC
5-(2-aminoethyl)benzene-1,2,4-triol
현지명
산화오파민
영어명
oxidopamine
분자식
C8H11NO3
분자량
169.18

이름 및 동의어

oxidopamine6-HYDROXYDOPAMINE1199-18-45-(2-aminoethyl)benzene-1,2,4-triol2,4,5-TrihydroxyphenethylamineOxidopamina6-OHDAOxidopaminum5-(2-Aminoethyl)-1,2,4-benzenetriol1,2,4-Benzenetriol, 5-(2-aminoethyl)-8HW4YBZ748DTXSID0036768
이름 더 보기
산화오파민D016627Oxidopamine hydrobromideHydrobromide, oxidopamine
CHEBI:78741NSC2338986 HydroxydopamineRefChem:857156Hydrochloride, OxidopamineDTXCID8016768214-842-3Topamine

데이터베이스 식별자

CAS
1199-18-4
PubChem CID
4624
DTXSID
DTXSID0036768
ChEMBL
CHEMBL337702
ChEBI
CHEBI:78741
UNII
8HW4YBZ748
EC Number
214-842-3
Nikkaji
J126K

물성

구조 계산 물성

XLogP
0.2
극성 표면적
86.7 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
4
회전 가능 결합 수
2
무거운 원자 수
12

실험 및 물리화학적 성질

Melting Point232 °C
Physical Description · 2건

6-hydroxydopamine is a solid. Used as a pharmacological agent.

Solid

Collision Cross Section · 2건

143 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

143.2 Ų [M+H]+

물리화학적 성질

끓는 점
298.46 °C · 298.46°C (rough estimate)
밀도
1.2435 · 1.2435 (rough estimate)
굴절률
1.51 · 1.5100 (estimate)
EPA
6 · 6-Hydroxydopamine (1199-18-4)

안전 및 규제

유해성 정보

DOT LabelPoison
Fire HazardsFlash point data for this chemical are not available. It is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Symptoms of exposure to this chemical may include a prolonged decomposition in catecholamine content of the heart (shown to be due to the destruction of sympathetic nerve endings). (NTP, 1992)
Reactive GroupAmines, Phosphines, and Pyridines
Reactivity Profile · 1건

Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.

Air and Water ReactionsNo rapid reaction with air. No rapid reaction with water.

안전 및 보호

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1건

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill ResponseSTORAGE PRECAUTIONS: You should store this material in a refrigerator. (NTP, 1992)
Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1건

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 2건

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.

Tissue LocationsAdrenal Medulla
Cellular LocationsCytoplasm

응용 분야

용도Adrenergic (ophthalmic).

일반 설명Solid. Used as a pharmacological agent.

공급사5 곳

陕西缔都新材料有限公司029-63373950 17392216152 · [email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
BOC Sciences16314854226 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
추가 설명 · 1건

정의ChEBI: A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Pa kinson's disease).

관련 반응

2건

연결된 노트

불러오는 중…